REG - Wellnex Life Limited - Expanded Financing Facility

Wellnex LifeAnnouncement

19/09/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250919:nRSS0372Aa&default-theme=true

RNS Number : 0372A  Wellnex Life Limited  19 September 2025

 

 

 

ASX/AIM
Announcement

 

19 September 2025

 

Wellnex Life Limited (ASX/AIM:WNX)

 

Expanded Financing Facility

Wellnex Life Limited (ASX/AIM: WNX) (Wellnex Life or Company) announces that, further to the Company's announcement on 31 July 2025, the Group has entered into an additional loan facility via Reach Wholesale ("Reach") for up to A$2.5 million (the "Additional Facility"). The Additional Facility, which is secured over the assets of the Group's key subsidiaries, is for a 24-month term at an interest rate of 14% for the term of the Additional Facility. The coupon and key terms are the same terms as the loan facility via Reach announced on 31 July 2025.

The Additional Facility will serve to ensure that the Company has the maximum
flexibility available to support continued growth in the business. A$1.31
million is being drawn down immediately under the Additional Facility, which
will be applied towards settlement of long-term obligations and towards
general working capital. A further drawdown of A$0.365 million is expected
shortly. The balance of A$0.825 million requires the prior approval of Reach
in their absolute discretion.

 

To stay up to date on company news and announcements, please register your
details on the Wellnex Life Limited investor portal:
(https://propell.investorportal.com.au/stay-up-to-date/)
https://wellnexlife.investorportal.com.au/register/
(https://wellnexlife.investorportal.com.au/register/)

This ASX/AIM announcement has been authorised by the Board of Wellnex Life
Limited (ASX/AIM:WNX).

For further information, please contact:

 

Wellnex Life Limited (ASX:WNX)
                                 Reach Markets

Zack Bozinovski
 
T: 1300 805 795

Chief Executive Officer & Managing
Director                  E: IR@reachmarkets.com.au
(mailto:IR@reachmarkets.com.au)

P: +61 3 8399 9419

E: zack.b@wellnexlife.com.au (mailto:zack.b@wellnexlife.com.au)

 

UK Investors

 

Strand Hanson (Financial & Nominated Advisor)

James Harris / Richard Johnson
                        Tel: +44 (0) 20 7409 3494

 

Orana Corporate LLP (Joint
Broker)
swykeham@oranacorp.com (mailto:swykeham@oranacorp.com)

Sebastian Wykeham

 

S.P. Angel Corporate Finance LLP (Joint Broker)
            Tel: +44 (0)20 3470 0470

David Hignell / Vadim Alexandre

 

 

 

 

About Wellnex Life

 

Wellnex Life Limited (ASX/AIM:WNX) is a consumer healthcare business with a
track record for developing, licensing, and marketing registered products and
brands to customers in the growing healthcare market segment. Since listing on
ASX in 2021, Wellnex Life has successfully launched a host of brands and
products now ranged in major retailers in the healthcare market space,
pharmacies and supermarkets. Its distribution arrangements have seen Wellnex
Life secure significant licensing arrangements with major pharmaceutical
companies in Australia and globally that have given the Company's registered
products a distribution channel with a steadily increasing global geographic
footprint.

 

In December 2023, Wellnex Life acquired leading Australian topical pain relief
brand Pain Away. Its addition to Wellnex Life's product offering both
compliments and accelerates the potential growth of the company's business
operations. This transformational acquisition gives added impetus to Wellnex
Life's financial growth and scale and reinforces its place as a major and
respected participant in the growing healthcare market, both in Australia and
overseas.

 

The information contained within this announcement is deemed by the Company to
constitute inside information pursuant to article 7 of EU Regulation 596/2014
as it forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 as amended.

 

To learn more, please visit: www.Wellnex Lifelife.com.au/
(https://wellnexlife.com.au/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCZZGMLKLZGKZG